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What predicts depression in cardiac patients: Sociodemographic factors, disease 
severity or theoretical vulnerabilities? 
Running title: Depressive vulnerabilities in cardiac patients 
Abstract 
Depression is associated with increased cardiovascular risk in patients with acute 
coronary syndrome (ACS), but some argue that elevated depression is actually a 
marker of cardiovascular disease severity. Therefore, disease indices should be better 
predictors of depression than established theoretical causes of depression 
(interpersonal life events, reinforcing events, cognitive distortions, type D 
personality). However, little theory-based research has been conducted in this area. In 
a cross-sectional design, hospitalised ACS patients (n=336) completed questionnaires 
assessing depressive symptoms and vulnerabilities. Nested logistic regression 
assessed the relative contribution of demographic or vulnerability factors, or disease 
indices or vulnerabilities to depression. In multivariate analysis, all vulnerabilities 
were independent significant predictors of depression. Demographic variables 
accounted for <1% of the variance of depression status, with vulnerabilities 
accounting for significantly more (pseudo R2=.16, χ2(change)=150.9, df=4, p<0.001). 
Disease indices accounted for 7% of the variance in depressive status (pseudo R2=.07, 
χ2=137.9, p<0.001). However, adding the vulnerabilities increased the overall 
variance explained to 22% (pseudo R2=.22, χ2=58.6, df=4, p<0.001). Theoretical 
vulnerabilities predicted depression status better than did either demographic or 
disease indices. The presence of these proximal causes of depression suggests that 
depression in ACS patients is not simply a result of cardiovascular disease severity. 
Keywords: Depression; acute coronary syndrome; psychological theory; life events; 
personality; just world beliefs  
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Introduction 
In persons with coronary heart disease (CHD), the prevalence of depression is 
elevated in comparison to general population samples (Jacobi et al., 2005; Thombs et 
al., 2006). Furthermore, depression has been associated with poorer prognosis in such 
patients (Barth, Schumacher, & Herrmann-Lingen, 2004; Nicholson, Kuper, & 
Hemingway, 2006), but the treatment of such depression does not improve prognosis 
(The ENRICHD Investigators, 2003; van Melle et al., 2007). Thus, some researchers 
have postulated that the association between depression and poorer prognosis simply 
reflects some confounding aspect of somaticised symptoms of disease severity. In this 
case, the symptoms of depression are assumed to arise from heart disease severity 
(Lane, Carroll, Ring, Beevers, & Lip, 2000; Lane, Lip, & Carroll, 2004), or patients 
are assumed to be simply adjusting naturally to a stressful life event (Frasure-Smith & 
Lesperance, 2003).  
 
When assessing the prognostic value of depression, studies regularly include a wide 
range of variables (e.g. Carney, Freedland, Miller, & Jaffe, 2002; de Jonge et al., 
2006; Frasure-Smith & Lesperance, 2008; Frasure-Smith, Lesperance, & Talajic, 
1993; Grace et al., 2005; Lane, Carroll, Ring, Beevers, & Lip, 2002; Nicholson, 
Kuper, & Hemingway, 2006; The ENRICHD Investigators, 2003). However, there is 
generally little correlation between coronary disease severity and depression (Carney, 
Freedland, Miller, & Jaffe, 2002). Furthermore, when statistically controlling for 
other established risk factors, the association between depression and prognosis 
remains (Barth, Schumacher, & Herrmann-Lingen, 2004; Nicholson, Kuper, & 
Hemingway, 2006). However, with such heterogeneous assessment of coronary 
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disease indices, it is difficult to establish whether all appropriate variables have been 
assessed, or if any potential mediating variables have been omitted. 
 
One alternative way to address this issue is to ask ‘What causes depression?’, rather 
than ‘What causes CHD?’. Much of the research into the association between 
depression and CHD has been atheoretical, and few studies have been conducted on 
the antecedents of depression in CHD patients. If depression is psychogenic, i.e. has 
its origin in theoretical proximal causes in CHD patients, then it can be argued that 
patients are depressed independently of CHD disease severity. Some of the well-
established theoretical causes of depression in the general population are stressful life 
events, reduced positive reinforcement, and distorted cognitions (Beck, 1991; 
Lewinsohn & Gotlib, 1995; Paykel, 2003). These proximal causes of depression have 
corresponding theories of causality and evidence-based interventions, respectively: 
interpersonal theory, behavioural theory and cognitive theory (Beck, 1991; Davidson, 
Rieckmann, & Lesperance, 2004; Kanter, Callaghan, Landes, Busch, & Brown, 2004; 
Lewinsohn & Gotlib, 1995). A further vulnerability is personality type (Enns & Cox, 
1997; Smith & MacKenzie, 2006). 
 
As a higher prevalence of depression is seen in the CHD population, these 
vulnerabilities should be elevated in depressed cardiac patients (Davidson, 
Rieckmann, & Lesperance, 2004). Only one study has demonstrated that several of 
these theoretical depressive vulnerabilities are present in the depressed cardiac 
population. Rieckmann et al. (2006) assessed 314 acute coronary syndrome (ACS) 
patients for depression within one week of hospital admission and reported that both 
mildly (29%) and moderately/severely (18%) depressed patients showed higher levels 
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of cognitive (dysfunctional attitudes), interpersonal (role transitions) and behavioural 
(reduced number of pleasant events) vulnerabilities. Also, these vulnerabilities 
independently contributed to depressive symptoms, i.e. no one vulnerability was 
mediated by another, although the presence of more than one vulnerability increased 
the odds of being depressed. These vulnerabilities also predicted depression status 
independently of sociodemographic factors in a hierarchical logistic regression model. 
However, results also demonstrated that substantial proportions of mildly depressed 
(25%) and moderately/severely depressed (14%) did not demonstrate any elevated 
vulnerability.  
 
The relative independence of the theoretical vulnerabilities highlights the complexity 
of depression in this population.  The finding that 14-25% of ACS patients have no 
vulnerability is intriguing. However, it is possible that the authors did not consider 
two key factors – cardiovascular disease severity indices, such as left ventricular 
ejection fraction (LVEF), were not included in the analyses, and LVEF may be a 
crucial confounder of the depression-CHD relationship (Barth, Schumacher, & 
Herrmann-Lingen, 2004; Nicholson, Kuper, & Hemingway, 2006; van Melle et al., 
2005); and ‘negative-prone’ personality was not considered as a vulnerability. Type D 
personality – the tendency to feel negative emotion across situations yet to inhibit 
these emotions – has been associated with increased depressive symptoms in several 
studies (Doyle, Conroy, & McGee, 2007; Pedersen & Denollet, 2006; Pedersen et al., 
2006). Pedersen et al. (2006) found that type D personality assessed at 6 months post-
event predicted the onset of depression in 542 patients 12 months after percutaneous 
coronary intervention. This was remarkable for two reasons. Firstly, none of the 
sample had depression at 6 months, and secondly, a new cardiac event occurring 6-12 
   
 6 
months from the initial recruitment into the study was not associated with onset of 
depression. Thus, type D can be considered a vulnerability factor for depressive 
symptoms, but it is unknown if type D accounts for the other vulnerabilities described 
above, or the category of individuals who did not show any elevated vulnerability.  
 
The aims of the present study were therefore: 1) to determine whether theoretical 
vulnerabilities to depression, including type D personality, independently predict 
depression status in patients with ACS; 2) to determine whether theoretical 
vulnerabilities independently predict depression status beyond demographic factors 
and cardiovascular disease severity indices. In other words, the study tests whether 
depressive symptoms are better accounted for by sociodemographic factors, disease 
severity indices or by theoretical vulnerabilities. 
 
Method 
Study design and participants 
The methods have been reported previously (Doyle, Conroy, McGee, & Delaney, in 
press). This paper presents data from a subgroup of ACS patients who completed 
questionnaires on theoretical vulnerabilities. Briefly, a multi-centre cross-sectional 
design was used to determine the association of vulnerabilities with depression. 
Twelve hospitals participated. Ethical approval was obtained as appropriate. 
Consecutive patients with confirmed ACS (myocardial infarction or unstable angina) 
who were literate in English were recruited by coronary care staff to participate in the 
survey during their hospital stay. Patients were asked for consent to access their charts 
at 12-months post-hospitalisation, and completed a composite psychological 
questionnaire. 
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CAD risk factors assessed as co-variates 
The main CAD risk factors assessed as co-variates in the present study included non-
modifiable characteristics (e.g. older age, male sex, history of CHD or cardiovascular 
disease, socioeconomic status [as assessed by the proxy of having private health 
insurance]), and modifiable characteristics including lifestyle (smoking, elevated 
cholesterol, hypertension, diabetes). Disease severity indices were also assessed using 
clinical or procedural indices (ejection fraction, revascularisation procedures during 
hospital stay) or other proxy variables (length of hospital stay). Major co-morbidities 
were also recorded, and later recoded as per the Charlson Comorbidity Index (CCI)  
(Han-Yi Wang, Ghee Chew, Kung, Kun-Jung Chung, & Lee, 2007). As this index 
contains some of the risk factors already assessed (e.g. MI, diabetes), a modified total 
score was generated to indicate the CCI score without these variables.  
 
Measures 
Depressive symptoms 
Hospital Anxiety and Depression Scale – Depression subscale (HADS-D) 
The HADS was developed to identify psychological disturbances in general medical 
and non-psychiatric samples (Zigmond & Snaith, 1983). It aims not to achieve 
contamination by omitting somatic symptoms which may be prevalent in these 
samples. The HADS consists of a 7-item depression scale (HADS-D) and a 7-item 
anxiety scale (HADS-A). The HADS-A was not used here. The optimal cut-off score 
is >7 for the HADS-D (Bjelland, Dahl, Haug, & Neckelmann, 2002; Roberts, 
Bonnici, Mackinnon, & Worcester, 2001), and this threshold is adopted in the present 
study. 
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Beck Depression Inventory – Fast Screen (BDI-FS) 
The BDI-FS is a 7-item screening instrument that minimises the possibility of 
yielding spuriously high estimates of depression for patients with medical problems 
by focusing on cognitive (as distinct from somatic) symptoms of DSM-IV criteria for 
depression (Beck, Guth, Steer, & Ball, 1997). Studies have consistently found that a 
BDI-FS cut-off score of >3 yields a sensitivity of >0.90 and specificity of >0.85 for 
detecting major depressive disorders (Beck, Steer, Ball, Ciervo, & Kabat, 1997; 
Scheinthal, Steer, Giffin, & Beck, 2001). In the present study, the suicidality item of 
the BDI-FS was omitted, for reasons outlined previously (Doyle, Conroy, McGee, & 
Delaney, in press; McGee, Doyle, Delaharpe, Shelley, & Conroy, 2006), with the 
recommended threshold of >3 maintained. 
 
Maastricht Questionnaire – 10 item (MQ-10) 
According to ICD-10 (World Health Organisation, 1993), a core diagnostic symptom 
of depression is fatigue. The above scales deliberately omit this symptom. ‘Vital 
exhaustion’ – a syndrome of fatigue, irritability and demoralisation – focuses mostly 
on fatigue (Doyle, Conroy, & McGee, 2007). However, the level of overlap between 
vital exhaustion and depression questions whether this construct is different from 
depression. Therefore, the brief 10-item version of the Maastricht Questionnaire 
(MQ-10; Appels, Hoppener, & Mulder, 1987) was considered a depression scale in 
the present study. The scale items are scored as binary (yes=1, no=0). The 
recommended cut-off score of >4 was used, as this has been shown to predict risk in 
both aetiological and prognostic studies (Appels, 2001). 
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Assessing depressive vulnerabilities 
List of Threatening Experiences Questionnaire (LTE-Q) 
The LTE-Q was used to assess the extent of interpersonal and life event difficulties 
that patients may have experienced in the year prior to their hospital admission. The 
LTE-Q is a 12-item scale which assesses stressful life events (Brugha, Bebbington, 
Tennant, & Hurry, 1985; Brugha & Cragg, 1990). Examples of life events on the 
LTE-Q are experiencing a serious illness or assault, or a relationship break-up. It has 
been shown to have high test-retest reliability in psychiatric patients, and compared 
well with an interview technique (sensitivity and specificity for stressful life events 
were between 0.89-1.0 and 0.74-0.88 respectively). The present study modified the 
question regarding serious illness (item 1: You yourself suffered a serious illness, 
injury or assault) to “illness (not including this current hospitalisation), injury or 
assault”.  
 
Pleasant Events Schedule – Alzheimer’s Disease (short version) (PES-AD) 
The PES-AD is a 20-item behavioural log that rates a number of pleasant events 
which people may enjoy doing. This scale was originally developed for persons with 
Alzheimer’s disease (Logsdon & Teri, 1997), but a variation has recently been used 
with ACS patients (Rieckmann et al., 2006). Ratings of the frequency of 
behaviours/events in the past month are understood to correspond to the rate of 
environmental engagement. Ratings of enjoyment are assumed to reflect positive 
reinforcement. As in previous research, missing items were coded as 0 if at least half 
of the 20 items had been answered (Rieckmann et al., 2006). A cross-product 
produced a total schedule score of positive reinforcement in the past month. As the 
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PES-AD is a schedule, not a scale, its items are theoretically independent. Thus, 
reliability statistics are meaningless.  
 
Belief in a Just World – Self scale (BJW-S) 
Cognitive distortions, as conceptualised by Beck (1991), were not considered as a 
theoretical causes of depression in the present study. Such cognitive distortions are 
only present in a minority of cardiac patients (Martens et al., 2006; Rieckmann et al., 
2006), they do not predict cardiovascular prognosis (de Jonge et al., 2006; Doyle, 
McGee, De La Harpe, Shelley, & Conroy, 2006), and the treatment of such symptoms 
with cognitive behavioural therapy does not reduce associated morbidity/mortality 
(The ENRICHD Investigators, 2003). However, a period of adjustment post-event is 
likely not only for those who have dysfunctional attitudes or distorted cognitions, but 
for most if not all patients. Therefore, what may be relevant is how all individuals 
adjust their world-view in regards to themselves and their place in the world post-
ACS – rather than the more self-focused depressive vulnerabilities/cognitions that 
may be prevalent in a minority of persons. Therefore, the concept of belief in a just 
world (BJW) – the belief that good things happen to good people, and bad things 
happen to bad people (Furnham, 2003) – was assessed. Previous research has shown 
that a ‘distorted’ BJW – i.e. believing that the world is not just – was associated with 
depression (Furnham, 2003; Lipkus, Dalbert, & Siegler, 1996), and that just world 
beliefs in regard to the self (rather than to others or the population in general) 
predicted psychological well-being independently of personality (Lipkus, Dalbert, & 
Siegler, 1996). BJW for self is assessed by the BJW-S, which is an 8-item scale, with 
a 6-point Likert answer format (Lipkus, Dalbert, & Siegler, 1996). It has not 
previously been used in a cardiac population. In the validation studies, seven items 
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loaded moderately to highly on a single factor, but one item was included despite an 
unsatisfactory item loading during factor analysis (Lipkus, Dalbert, & Siegler, 1996). 
An overall Cronbach’s α was not reported.  
 
For comparability among measures in the present study, and in line with previous 
research (Rieckmann et al., 2006), the scores of the vulnerability scales above were 
categorised. The PES-AD and the BJW-S were reverse scored, and then recoded so 
that the upper quartile indicated a greater theoretical vulnerability to depression (i.e. a 
lack of positive reinforcement, not believing in a just world). Scales were divided into 
quartiles, and then recoded to compare the upper quartile (=1) with the others (=0). 
 
Type D scale – DS14 
The DS14 is a 14-item scale which measures whether or not participants have a 
distressed (type D) personality type (Denollet, 2005). The DS14 consists of two 7-
item scales assessing negative affectivity (NA) and social inhibition (SI). A cut-off of 
10 on both scales indicates those of the type D personality disposition. The DS14 has 
been used extensively in cardiac patients, and it has demonstrated good psychometric 
properties. The NA and SI scales have demonstrated internal consistencies (α) of 0.86 
and 0.88, and three-month test re-test reliabilities of 0.72 and 0.82 respectively 
(Denollet, 2005). 
 
Statistics 
Logistic regression was adopted to allow prediction of binary dependent variables, 
using odds ratios (ORs) as a measure of effect size. Depression was classified as 
scoring above threshold on any of the scales, as this was most comparable to the 
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results found by Rieckmann et al. (2006). Univariate and multivariate logistic 
regression was used to assess differences between depressed and non-depressed 
samples. Demographic and disease variables which predicted depression with a p-
value <.15 were included in the multivariate analyses, omitting variables with large 
numbers of missing values. Nested logistic regression was used to predict the unique 
contribution of blocks of variables (sociodemographics or disease indices as block 1, 
vulnerabilities as block 2; the sample size did not allow the inclusion of both at the 
same time). Nested logistic regression differs from hierarchical regression in that it 
allows blocks of variables to co-vary with the addition of subsequent blocks, whereas 
hierarchical regression fixes the variance explained for each block. Goodness-of-fit 
statistics (χ2, pseudo r2 and F-statistics) were utilised to assess the prediction of 
depressive symptoms by theoretical vulnerabilities. The pseudo r2 statistic only 
approximates the r2 statistic in linear regression analyses, and cannot be interpreted as 
such. To account for original clustering of patients within hospitals, analysis was 
conducted using Huber-White robust variance estimation adjusted standard errors. 
Missing data was imputed for depression scales, BJW-S and the DS14 scale using 
Stata SE 9.2’s regression-based ‘impute’ command (see Doyle, Conroy, McGee, & 
Delaney, in press). Regression-based imputation performs well in comparison to 
inputting the mean, median or last observation carried forward (Shrive, Stuart, Quan, 
& Ghali, 2006). For life events and pleasant events, missing data imputation was 
inappropriate. 
 
Results 
The baseline profile of the sample has been reported previously (Doyle, Conroy, 
McGee, & Delaney, in press). Data from 339 participants with fully completed 
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vulnerability questionnaires were analysed. Data were compared for those scoring 
above cut off on any of the HADS-D, BDI-FS or MQ-10 (48%) – Table 1.  
 
--------------- 
Insert Table 1 here 
-------------- 
 
More non-depressed participants had private health insurance, but no other 
demographic variables differed between subgroups. Depressed participants were more 
likely to be smokers, to have diabetes, to have lower levels of cholesterol, and have 
higher prevalence of past CHD and revascularisation. No differences were seen in 
terms of treatments received for the index hospitalisation. The prevalence of elevated 
vulnerabilities was significantly higher in depressed patients.  
 
Proportions of vulnerabilities reported 
The number of vulnerabilities reported by proportions of the sample, stratified by 
depression status, is displayed in Fig 1. 
 
-------------- 
Insert Fig 1 here 
-------------- 
 
Of those scoring above thresholds on given depression scales, 22% demonstrated no 
theoretical vulnerability to depression. Thus, type D did not account for the 
proportion of patients who did not exhibit any vulnerability as found by Rieckmann et 
al. (2006), although it was the only vulnerability reported by 13% of those with 
elevated depressive symptoms. However, the elevated levels of depressive symptoms 
seen in Rieckmann et al. (2006), and above, suggests that this is an overestimation of 
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those with elevated depressive symptoms. Using a more realistic estimate of 
depressive symptoms (the proportion of individuals who scored in the top quintile of 
depressive symptoms according to at least one scale – 29%) leads to a different 
answer – <4% of depressed patients did not exhibit any vulnerability (other data not 
shown).  
 
Predicting depression: multivariate analyses 
The first model, predicting depression status using demographic and vulnerability 
factors (variables with a p-value<.15), is displayed in Table 2 (a). The demographic 
factors in block 1 predicted <1% of the model (pseudo R2=.008, χ2=4.0, df=4, 
p=.134), but the addition of theoretical vulnerabilities in block 2 increased the 
proportion of the model explained by a significant margin (χ2=150.9, df=4, p<0.001), 
with the model now explaining 16% of the variance (overall model fit: pseudo 
R2=.16, χ2=166.5, p<0.001). Thus, the vulnerabilities were far more important than 
demographic factors for prediction of depression in this sample. 
 
------------- 
Table 2 here 
------------ 
 
The analysis was repeated with block 1 consisting of risk factor and disease severity 
indices (current smoker, prior diabetes, prior CHD, prior or current revascularisation, 
cardiac arrest), and block 2 consisting of the vulnerabilities. The results are in Table 2 
(b). This first block of disease severity variables accounted for 7% of the variance in 
depressive status (pseudo R2=.07, χ2=137.9, p<0.001). However, the vulnerabilities 
added significantly to the model (χ2=58.6, df=4, p<0.001), with the overall variance 
explained increasing to 22% (pseudo R2=.22, χ2=156.0, p<0.001). Thus, 
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psychological vulnerabilities accounted for significant variation in depression not 
explained by disease severity.  
 
Discussion 
The aim of this study was to determine if theoretical vulnerabilities to depression, 
including type D, were independent predictors of depression in ACS patients, and to 
determine if these vulnerabilities were better predictors of depression than 
sociodemographics or indices of cardiovascular disease. Results showed that the 
vulnerabilities were more powerful predictors of depression status than demographic 
or disease variables, and moreover that these vulnerabilities were each independent 
predictors of depression. 
 
The vulnerabilities assessed here show good comparability to previous research 
(Lipkus, Dalbert, & Siegler, 1996; Pedersen & Denollet, 2006; Rieckmann et al., 
2006; Schiffer et al., 2006), suggesting that the findings should have a degree of 
generalisability. The present study argued that the presence of depressive 
vulnerabilities would provide evidence that patients were depressed independently of 
the ACS event or severity. In univariate and multivariate nested regression analyses, 
all vulnerabilities predicted depression. These results support the results of 
Rieckmann et al. (2006), but extend these findings in two ways. First, vulnerabilities 
predicted depression status beyond coronary disease markers, including LVEF. 
Second, the result that type D personality was an independent predictor of depressive 
symptoms, when controlling for other established vulnerabilities, has not previously 
been demonstrated in the literature.  
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Rieckmann et al. (2006) showed that a category of depression may exist that cannot 
be attributed to particular theoretical vulnerabilities, with between 14-25% of 
depressed persons (who constituted 47% of their sample) not exhibiting any assessed 
vulnerability. However, the authors did not assess personality disposition as a possible 
vulnerability. Although type D did not account for all of this residual category in the 
current study, this category of depression was smaller when a more conservative (and 
probably more realistic) threshold criterion was used for depression. Thus, in this 
instance, it could be argued that type D did account for the majority of the remaining 
depressed individuals who did not display vulnerabilities in Rieckmann et al. (2006). 
Indeed, type D was the only vulnerability reported by 13% of those with depression 
(according to original thresholds). Furthermore, the differences in findings seen in the 
Rieckmann et al. (2006) study could also be attributable to the differences in 
categorising of vulnerabilities. For example, Rieckmann et al. (2006) typically used 
the upper standard deviation (typically about 16% in a normally distribution), whereas 
the present study used upper quintiles. Thus, the residual ‘atheoretical’ category may 
depend on not only how depression is defined as ‘elevated’, but also how the 
vulnerabilities are defined as ‘elevated’. A further possibility is that there are likely a 
proportion of patients who are having what would be considered adjustment which 
will abate naturally over time, rather than actual ‘depression’ (Frasure-Smith & 
Lesperance, 2003) – and these could explain the residual category also.  
 
The results of the present study provided support for the notion that vulnerabilities to 
depression were more important for depression than were demographic or 
cardiovascular disease variables. The first multivariate model tried to replicate 
Rieckmann et al. (2006), who had found that although demographic variables were 
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significant predictors of depressive symptoms, the vulnerabilities were more strongly 
associated with depression. In the present study, demographic variables accounted for 
very little of depression status – less than 1% of the model was explained by these 
factors. The vulnerabilities showed a significant improvement in model fit, and 
demonstrating that these vulnerabilities were a much more powerful predictor of 
depression. Furthermore, all vulnerabilities remained significant independent 
predictors in the nested model, showing that no vulnerability was mediated by 
another, replicating the previous research. 
 
Although depression was not associated with most cardiovascular disease severity or 
risk marker indices, these variables did explain a significant, albeit small (7%), 
proportion of the model in depression in the present study. It is important to highlight 
that these disease variables did not account for the bulk of the variance in the data, 
and vulnerabilities accounted for significantly more of the model. This supports other 
work which has shown that there is little or no association between cardiovascular 
disease severity indices and depression (Carney, Freedland, Miller, & Jaffe, 2002; 
Lane, Carroll, Ring, Beevers, & Lip, 2000; Parker et al., 2008; Sorensen et al., 2005). 
Furthermore, LVEF<40% did not discriminate between depressed and non-depressed 
patients, and was therefore not included in the multivariate analysis. However, 
including this variable did not significantly change the results (data not shown). This 
is perhaps surprising given the previously outlined findings that depression was more 
prevalent in those with LVEF <30% (van Melle et al., 2005). However, it may be that 
LVEF needs to be lower than 30% for these hypothesised effects on depression to 
occur. A further issue is the instrument used in that study – the full-length BDI scale 
assesses multiple somatic symptoms, which were omitted from the present research. 
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These symptoms may be simply indicative of CHD symptoms, or even medication 
side-effects (e.g. insomnia, fatigue). Thus, these methodological differences could 
account for the findings. Overall, these results suggest that the demographic, disease 
and treatment indices measured in the present study are unlikely to explain the 
prevalence of depression – irrespective of whether this prevalence is better accounted 
for by the theoretical vulnerabilities or not. 
 
If depression in ACS patients is mainly attributed to least one of the vulnerabilities, 
then theoretically it could be argued that such depression is independent of CHD 
severity, as these vulnerabilities should be independent of CHD severity. For 
example, diabetes does not cause (non-health) stressful life events, high cholesterol 
does not lessen our enjoyment of music or how often we listen to it, and high blood 
pressure does not cause us to think that the world is an unfair place. This is not to say 
that prognostic studies should not control for disease severity indices, but this 
provides an alternative test of whether or not these patients should be considered 
depressed, rather than simply adjusting to a life event.  
 
The cross-sectional nature of this vulnerability-related data precludes definitive 
conclusions about directionality or causality of the associations assessed in this study. 
However, most of the vulnerabilities assessed have predicted depression in 
longitudinal studies, and some are also pertinent for the treatment of depression. As 
such, these findings may carry an element of weight with regard to the hypothesised 
directionality of the relationship. However, previous research has demonstrated a bi-
directional relationship between theoretical causes of depression and depressive 
symptoms, which may have affected present findings. The PES-AD may be 
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influenced by the negative and pessimistic outlook or response set of depressed 
individuals (Lewinsohn & Gotlib, 1995). Other studies have demonstrated that 
although depressed patients report experiencing more life events, depression may 
actually predispose people to be exposed to further life events, e.g. 
miscommunication between depressed and non-depressed partners causing further 
marital conflict (Joiner, 2002; Paykel, 2003; Weissman & Markowitz, 2002). There 
may also be an element of recall bias, with depressed patients more likely to recall 
negative events than non-depressed counterparts (Lewinsohn & Gotlib, 1995; Monroe 
& Hadjiyannakis, 2002). However, reliability studies support the view that severe life 
events are recalled and reported accurately for up to 10 years (Monroe & 
Hadjiyannakis, 2002). It could be argued that the BJW-S is not a comprehensive 
measure of cognitive distortions. However, the present findings showed that the BJW-
S was predictive of depression independently of other vulnerabilities, and this 
supports previous findings that the BJW-S predicted depression independently of 
personality traits (Lipkus, Dalbert, & Siegler, 1996). Furthermore, there was no 
measure of BJW prior to the event; therefore it is impossible to know if depressive 
symptoms associated with lower BJW-S scores were as a result of a ‘disrupted’ BJW. 
Importantly, no measure of psychiatric history was available. Sorensen et al. (2005) 
have shown that previous depression was associated with depression at discharge 
post-ACS, and that those with a history of depression had more severe depression. 
Longitudinal studies are required to assess whether ACS patients with such 
vulnerabilities are at greater risk for developing future depressive episodes.  
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Conclusions 
This study replicates and further extends the previous findings of Rieckmann et al. 
(2006), by showing that Type D personality can also be considered an independent 
vulnerability factor for elevated depressive symptoms during hospitalisation for ACS. 
The results of this study imply that there is very little association between disease 
severity indices and depression, but that the depressive symptoms were better 
accounted for by elevated vulnerabilities to depression. This suggests that these 
depressive symptoms are present independently of the ACS event. 
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Table 1: Demographic and risk factor profile of the current sample (n=336 unless 
otherwise stated), categorised by having elevated depressive symptoms or not 
Variable No 
depressive 
symptoms 
(n=209) 
Elevated 
depressive 
symptoms 
(n=199) 
Odds-
ratio 
(OR) 
95% 
confidence 
interval (CI) 
p 
Demographics       
Age (years)(mean, std dev) 61.7 (11.1) 60.5 (10.4) 0.99 0.96 1.004 0.118 
Men 86% 83% 0.8 0.4 1.8 0.648 
Has a partner (1=yes) 73% 75% 1.1 0.7 2.0 0.585 
Employed (1=yes) (n=252) 23% 15% 0.9 0.5 1.6 0.746 
Private health insurance 35% 28% 0.7 0.5 1.0 0.053 
Current risk factor profile       
Current smoker 28% 42% 1.9 1.5 2.4 <0.001*** 
Prior hypertension 45% 44% 1.0 0.7 1.5 0.938 
Prior diabetes 4% 14% 3.7 1.9 7.6 <0.001*** 
Total cholesterol 
(mmol/l)(mean, SD) (n=252) 4.8 (1.2) 4.4 (1.2) 0.8 0.6 0.9 0.001** 
Prior CHD 25% 34% 1.6 1.0 2.4 0.041* 
Prior revascularisation 20% 29% 1.7 1.0 2.7 0.031* 
Current hospitalisation       
Thrombolysis 28% 20% 0.7 0.3 1.3 0.234 
Revascularisation received 75% 66% 0.6 0.4 1.1 0.080 
Cardiac arrest confirmed 18% 12% 0.6 0.3 1.1 0.120 
Length of hospital stay 
(median, interquartile range 
[IQR]) 
7 (5–11) 7 (4–10) 0.99 0.96 1.02 0.546 
Left ventricular function 
(confirmed as <40%) 16% 12% 0.8 0.4 1.6 0.479 
Co-morbidities       
Modified CCI score (median, 
IQR) 0 (0–0) 0 (0–1) 1.1 0.95 1.4 0.154 
Vulnerability scales       
Life events: LTE-Q^ (median, 
IQR)  0 (0–1) 2 (1–3) 4.7 2.1 10.5 <0.001*** 
Reinforcing events: PES-AD^ 
(median, IQR) 27 (23–31) 24 (20–30) 2.2 1.5 3.2 <0.001*** 
Cognitions: BJW-S^ (median, 
IQR) 34 (32–36) 31.5 (27–35) 4.0 2.5 6.4 <0.001*** 
Personality: Type D 17% 44% 3.9 2.3 6.7 <0.001*** 
*<0.05, **<0.01, ***<0.001 
^analysed as top quartile (1) versus the rest (0) 
   
 29 
 
63%
22%
25%
36%
10%
27%
2%
10%
5%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
No depressive
symptoms
Elevated depressive
symptoms
Depression (any scale)
P
a
ti
e
n
ts
 (
%
) Four
Three
Two
One
None
 
Fig 1: Number of vulnerabilities reported by participants, stratified by depressive 
symptom status 
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Table 2: Nested logistic regression model predicting depression with vulnerabilities, 
demographic (a) and disease severity (b) 
a) OR 95% CI p 
Block 1 - demographics     
Age 1.0 0.98 1.03 0.818 
Private health insurance (1=yes) 0.9 0.6 1.3 0.472 
Block 2^     
LTE-Q (Stressful life events) 3.8 1.8 8.1 0.001** 
PES-SV (low reinforcement) 2.1 1.3 3.3 0.002** 
BJW (non-belief in a just world) 2.8 1.8 4.3 <0.001*** 
Type D personality (modified) 3.1 1.9 5.3 <0.001*** 
b)     
Block 1 – Risk factor and disease severity     
Current smoker 2.5 1.8 3.3 <0.001*** 
Diabetes 5.5 2.8 10.6 <0.001*** 
Prior CHD 0.9 0.6 1.5 0.800 
Prior revascularisation 1.6 0.9 2.8 0.136 
Revascularisation post-event 0.6 0.3 1.0 0.051 
Cardiac arrest 0.5 0.3 0.9 0.016* 
Block 2 Vulnerabilities^     
LTE-Q (Stressful life events) 3.8 1.9 7.7 <0.001*** 
PES-SV (low reinforcement) 2.0 1.3 3.1 <0.001*** 
BJW (non-belief in a just world) 2.9 1.7 4.9 <0.001*** 
Type D personality 3.7 2.1 6.3 <0.001*** 
Variables which partially discriminated (p<.15) between elevated depressive symptoms and no 
depressive symptoms were included in the models 
*<0.05, **<0.01, ***<0.001 
^analysed as top quartile (1) versus the rest (0) 
 
 
